Indeed, mRNA vaccines designed to treat cancer (among ... as the plague — a disease that still kills thousands in Asia and parts of Africa each year. Anna Blakney, an RNA researcher at the ...

A new type of coronavirus vaccine administered nasally has proven effective when tested on animals, researchers at the ...

While mRNA vaccines may seem very new ... Once activated, the various parts of your immune system work together to generate an immune response to the antigen, which can include antibodies and ...

One problem with the first generation of mRNA medicines is that scientists don’t have great ways to control which parts of the body they get into. Strand has devised a technology that lets mRNA ...

After battling COVID-19 for over four years, just as the world was beginning to return to a sense of normalcy, a fresh wave ...

In contrast, traditional vaccines contain weakened or dead viruses or parts of viruses, which also trigger an immune response. Both mRNA vaccines and traditional vaccines have advantages and ...

The success of these COVID-19 vaccines is remarkable and was far from guaranteed. mRNA is incredibly delicate. Enzymes in the environment and in our bodies are quick to chop mRNA into pieces ...

With the help of mRNA technology proven effective during the COVID pandemic, researchers are now closer than ever to creating viable cancer vaccines. In an interview with Wired, Lennard Lee ...

Personalized mRNA vaccines show promise as pancreatic cancer ... Pancreatic cancer cells also spread to other parts of the body much earlier on than in other cancers, which typically spread ...

Drug manufacturers and experts say that noninfectious parts of the SV40 virus’ DNA ... Steve Kirsch made alarming allegations about mRNA COVID-19 vaccines. "You can now sue the mRNA COVID ...

MRNA technology is facing growing doubts among Republicans. This is a KFF Health News story. Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology ...

Other parts of the NIH like the National Cancer Institute also fund this work, because mRNA technology holds promise for targeted cancer treatment. "I am on pins and needles constantly," says ...